Clinical Trials Browser

Approved for marketing × GIST × avapritinib × Clear all

NCT03862885 2020-07-27

Early Access Program (EAP) for Avapritinib in Patients With Locally Advanced Unresectable or Metastatic GIST

Approved for marketing

GIST